News Conference News HFSA 2022 New Dapagliflozin Insights: Early Benefits and Types of Deaths Prevented Todd Neale October 07, 2022
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Daily News Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use L.A. McKeown October 05, 2022
News Conference News HFSA 2022 GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions Michael O'Riordan October 04, 2022
News Conference News HFSA 2022 Dapagliflozin’s Benefits Similar in HF Patients With Improved EF: DELIVER Todd Neale October 04, 2022
News Daily News Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues Michael O'Riordan October 03, 2022
News Daily News mRNA Vaccine-Linked Myocarditis Resolves in Time, Without Clinical Events Michael O'Riordan September 26, 2022
News Conference News TCT 2022 Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances Caitlin E. Cox September 19, 2022
Presentation TCT 2022 TCT 777: Impella-assisted intracoronary lithotripsy of heavily calcified left main lesion in a patient with severely impaired ejection fraction and the last remaining patent vessel Presenter: Marta Bujak September 19, 2022
Presentation TCT 2022 TCT 764: An uncrossable lesion of ostial flash chronic total occlusion in right coronary artery in heart failure with reduced ejection fraction: debulking atherectomy successfully performed to triple vessel disease. Presenter: Toru NAKANISHI September 18, 2022
Presentation TCT 2022 TCT 104: Impact of Left Ventricular Ejection Fraction (EF) on 10-year Mortality after Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG) : Is CABG Safer Than PCI in all Patients With Reduced Ejection Fraction (rEF) ? Presenter: Patrick Serruys September 18, 2022
Presentation TCT 2022 TCT 342: Early Multi-center Clinical Outcomes of a No-Implant Interatrial Shunt for Heart Failure with Preserved and Reduced Ejection Fraction: Latest Results From the Early Feasibility ALLEVIATE-HF Programs Presenter: Roxana Mehran September 18, 2022
Presentation TCT 2022 Case #2: MVD With Low Ejection Fraction (High-Risk for CABG) Presenter: Arnold Seto September 17, 2022
News Conference News TCT 2022 HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza Todd Neale September 16, 2022
News Daily News Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive Michael O'Riordan September 09, 2022
News Daily News Older Adults See Rebound in Rates of HF-Related Death: CDC Data Caitlin E. Cox September 09, 2022
News Conference News ESC 2022 ESC Revamps Guidelines on Ventricular Arrhythmias, Sudden Cardiac Death Todd Neale September 02, 2022
News Conference News ESC 2022 DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum Todd Neale August 27, 2022
News Conference News ESC 2022 Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR L.A. McKeown August 27, 2022
News Conference News ESC 2022 PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2 Michael O'Riordan August 27, 2022